TITLE

Expanded Access:

AUTHOR(S)
Huber, Jeffrey T.; Gillaspy, Mary L.
PUB. DATE
October 2000
SOURCE
Encyclopedic Dictionary of AIDS-Related Terminology;2000, p87
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "Expanded Access" is presented. It refers to a program that allows persons who meet certain criteria but are not enrolled in a clinical trial to receive an experimental drug. Under the program, the administering physician monitors the person's response to the drug, and reports the results to the pharmaceutical company that manufactures the experimental drug.
ACCESSION #
23075690

 

Related Articles

  • How to Find a Trial. Smith, Ian K. // Time International (South Pacific Edition);11/22/99, Issue 47, p76 

    Offers information on patient enrollment in clinical drug trials. Researchers' need for patients as well as patients' need for treatment; Reasons adults do not participate in clinical drug trials; Where to locate trials. INSETS: Ace-ing It;Inside Information;Minitel Mini-Stroke;Couch Potatoes...

  • Dying for a Cure. Kaplan, Sheila; Brownlee, Shannon // U.S. News & World Report;10/11/99, Vol. 127 Issue 14, p34 

    Offers information on the difficulties of clinical trials of experimental drugs in the United States. Problems with the trials, including neglect to report reactions to the drugs and failure by doctors to inform patients of the benefits and risks of a study; Effects of these problems, including...

  • Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers. Cabarrocas, X.; Salva, M.; Pavesi, M.; Costa, J. // International Journal of Clinical Pharmacology & Therapeutics;2006, Vol. 44 Issue 9, p443 

    Objective: A number of clinical reports have revealed a link between the use of alcohol and the onset or exacerbation of migraine headaches. This open, randomized, crossover, single-dose, phase I clinical trial evaluated the possible pharmacokinetic interactions between a single oral dose of...

  • Conducting Trials in Croatia. Aralica, Josip // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p46 

    The article reports on the clinical research projects in Croatia while not being part of the European Union (EU). It mentions that European countries, even if not part of the EU, is not a hindrance to producing high-quality clinical research and meeting the target for the number of subjects....

  • Great Expectations: CROs Face Change in Italy. Corrado, Mario // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p50 

    The article reports on the turbulent period of the clinical trials in Italy. It states that the country has a heterogeneous topology of the Contract Research Organizations (CRO) while the number of new trials per year has increased consistently from 500 in 2000 to 800 in 2007. On the other hand,...

  • Funding a Clinical Trial: The Perspective of a Medicines Funder. Alsop, Peter; Metcalfe, Scott; Evans, Jackie // PharmacoEconomics;2008, Vol. 26 Issue 10, p811 

    The article discusses the role of funding agencies in clinical trials. Well documented examples of industry-funded research not addressing important public good questions are presented. It is said that public funders of medicines actively seek information in addition to that provided by funding...

  • Trials shock fuels public interest.  // European Pharmaceutical Executive;May/Jun2006, p16 

    The article reports on how the Parexel clinical trial elicited a surge of interested volunteers from the general public. Enter Trials is a web site through which patients can register to participate in clinical trials. It reported that after the Parexel incident, its server hits rose from...

  • Global Clinical Trials Activity in the Details. Getz, Kenneth A. // Applied Clinical Trials;Sep2007, Vol. 16 Issue 9, p42 

    The article focuses on the increasing number of U.S. Food and Drug Administration (FDA) regulated principal investigators that are conducting clinical trial activities outside the U.S. An analysis conducted by the Tufts Center for the Study of Drug Development reveals that the number of active...

  • Press One for Safety. Meinert, Lawrence; Ward, Hal // Applied Clinical Trials;Sep2007, Vol. 16 Issue 9, p46 

    The article focuses on the concept that can be used by clinical trials professionals in determining the total number of exposed patients in clinical trials. The author points out the use of an Interactive Voice Response (IVR) systems which will improve the practitioner's understanding of adverse...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics